New drug trial aims to free patients from frequent blood transfusions
NCT ID NCT05732961
Summary
This study is testing whether the drug luspatercept can help adults with anemia from certain lower-risk bone marrow disorders become less dependent on regular blood transfusions. Researchers will enroll about 70 participants who currently need frequent transfusions and see if adding luspatercept to their standard care reduces that need. The trial will also closely monitor the drug's safety and how well participants tolerate it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.